Insulet Corp. (PODD) vs Shoulder Innovations, Inc. (SI)
A side-by-side comparison of Insulet Corp. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 5, 2026. Differences are shown without an overall score or investment verdict.
PODD
Insulet Corp.
$133.26HealthcareDelayed quote: Aug 5, 2026, 4:00 PM EDT
SI
Shoulder Innovations, Inc.
$22.60HealthcareDelayed quote: Aug 5, 2026, 4:00 PM EDT
Total return — PODD vs SI
growth of $100 · dividends reinvested · last 1yPODD -42.8%SI +50.8%SI compounded faster
PODD SI
PODD vs SI: by the numbers
- •PODD is the larger company ($9.23B vs $469M market cap).
- •PODD is profitable (10.44% net margin) while SI runs a net loss (-81.78%).
Metrics side by side
Valuation
| Metric | PODD | SI |
|---|---|---|
| P/E ratio | 38.80 | N/A |
| Forward P/E | 25.73 | N/A |
| P/S ratio | 4.04 | 8.66 |
| P/B ratio | 8.99 | 3.51 |
| PEG ratio | 0.39 | N/A |
| EV / EBITDA | 20.02 | N/A |
| FCF yield | 3.52% | N/A |
Profitability
| Metric | PODD | SI |
|---|---|---|
| Gross margin | 71.01% | 75.48% |
| Operating margin | 17.48% | -57.48% |
| Net margin | 10.44% | -81.78% |
| ROE | 23.25% | -33.14% |
| ROIC | 13.62% | -14.80% |
Growth (annualized)
| Metric | PODD | SI |
|---|---|---|
| Revenue CAGR (5Y) | 24.79% | N/A |
| EPS CAGR (5Y) | 99.91% | N/A |
| Total return CAGR (5Y) | -9.79% | N/A |
Frequently asked
- Is PODD or SI more profitable?
- PODD runs the higher net margin — PODD at 10.44% versus SI at -81.78%.
Go deeper
Dig into the metrics
Insulet P/E ratioShoulder Innovations P/E ratioInsulet dividend yieldShoulder Innovations dividend yieldInsulet ROEShoulder Innovations ROEInsulet operating marginShoulder Innovations operating marginInsulet revenue growthShoulder Innovations revenue growthInsulet free cash flowShoulder Innovations free cash flow
Insulet & Shoulder Innovations appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 5, 2026.